MTOR and cancer: The over-activated PI3K/Akt/mTOR pathway leads to the manifestation of a variety of cancer hallmarks, including growth signal autonomy, evasion of apoptosis, induction of angiogenesis, tissue invasion and metastasis, and insensitivity to antigrowth signals [6,7].